Cargando…

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease

Changes in intestinal microbiome and barrier function are critical in the development of alcohol-related liver disease (ALD). Here, we determined the effects of a one-week alcohol withdrawal on parameters of intestinal barrier function in heavy drinkers with ALD in comparison to healthy non-drinkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Finn, Burger, Katharina, Staltner, Raphaela, Brandt, Annette, Mueller, Sebastian, Bergheim, Ina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153596/ https://www.ncbi.nlm.nih.gov/pubmed/34068838 http://dx.doi.org/10.3390/nu13051659

Ejemplares similares

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Fructose: a modulator of intestinal barrier function and hepatic health?
por: Staltner, Raphaela, et al.
Publicado: (2023)

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
por: Burger, Katharina, et al.
Publicado: (2023)

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
por: Nier, Anika, et al.
Publicado: (2017)

A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women
por: Jung, Finn, et al.
Publicado: (2022)

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs
por: Jung, Finn, et al.
Publicado: (2022)

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice
por: Rajcic, Dragana, et al.
Publicado: (2023)

Acute Intake of Sucrose but Not of the Intense Sweetener Sucralose Is Associated with Post-Prandial Endotoxemia in Healthy Young Adults—A Randomized Controlled Trial
por: Staltner, Raphaela, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
por: Nier, Anika, et al.
Publicado: (2018)

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'
por: Brandt, Annette, et al.
Publicado: (2022)

Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions
por: Brandt, Annette, et al.
Publicado: (2023)

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
por: Brandt, Annette, et al.
Publicado: (2018)

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Exploring Alcohol Withdrawal Syndrome
por: Finn, Deborah A., et al.
Publicado: (1997)

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
por: Rajcic, Dragana, et al.
Publicado: (2020)

Phenobarbital for Alcohol Withdrawal: Rapid Patient Disposition
por: Richards, John R.
Publicado: (2000)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging
por: Untersmayr, Eva, et al.
Publicado: (2022)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Prevention of alcohol withdrawal seizure recurrence and treatment of other alcohol withdrawal symptoms in the emergency department: a rapid review
por: Koh, Justin Jek-Kahn, et al.
Publicado: (2021)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2021)

Correction to: Prevention of alcohol withdrawal seizure recurrence and treatment of other alcohol withdrawal symptoms in the emergency department: a rapid review
por: Koh, Justin Jek-Kahn, et al.
Publicado: (2022)

LORAZEPAM FOR ALCOHOL WITHDRAWAL
por: Andrade, Chittaranjan
Publicado: (2003)

Treatment of Alcohol Withdrawal
por: Myrick, Hugh, et al.
Publicado: (1998)

Kindling in Alcohol Withdrawal
por: Becker, Howard C.
Publicado: (1998)

Introduction to Alcohol Withdrawal
por: Saitz, Richard
Publicado: (1998)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Alcohol Dependence, Withdrawal, and Relapse
por: Becker, Howard C.
Publicado: (2008)

Animal Models of Alcohol Withdrawal
por: Becker, Howard C.
Publicado: (2000)

Alcohol Withdrawal with Delirium Tremens
por: Schwebach, Courtney, et al.
Publicado: (2023)

Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice
por: Ritze, Yvonne, et al.
Publicado: (2014)

Effects of Alcohol Dependence and Withdrawal on Stress Responsiveness and Alcohol Consumption
por: Becker, Howard C.
Publicado: (2012)

Catatonia in mixed alcohol and benzodiazepine withdrawal
por: Basu, Aniruddha, et al.
Publicado: (2014)

Baclofen versus lorazepam for alcohol withdrawal
por: Garag, Sagar S., et al.
Publicado: (2019)

Neurochemical Mechanisms Underlying Alcohol Withdrawal
por: Littleton, John
Publicado: (1998)

Complications of Alcohol Withdrawal: Pathophysiological Insights
por: Trevisan, Louis A., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_3hstogl0gpjie3d19elll33g7p